WELLS FARGO & COMPANY/MN - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$3,033,612
-31.4%
216,533
-49.4%
0.00%0.0%
Q2 2023$4,424,998
+13.1%
427,537
+0.9%
0.00%0.0%
Q1 2023$3,913,510
+13.4%
423,540
+8.8%
0.00%0.0%
Q4 2022$3,451,982
+5.5%
389,175
-1.0%
0.00%0.0%
Q3 2022$3,271,000
+2.2%
393,138
+0.6%
0.00%0.0%
Q2 2022$3,200,000
+44.7%
390,663
+53.8%
0.00%0.0%
Q1 2022$2,212,000
+36.1%
253,992
+48.6%
0.00%
Q4 2021$1,625,000
-28.1%
170,893
+27.1%
0.00%
Q3 2021$2,260,000
+643.4%
134,437
+575.0%
0.00%
Q2 2021$304,000
+266.3%
19,916
+368.3%
0.00%
Q1 2021$83,000
-86.5%
4,253
-87.5%
0.00%
Q4 2020$613,000
+12.1%
34,021
+19.9%
0.00%
Q3 2020$547,000
-36.3%
28,368
-13.7%
0.00%
Q2 2020$859,000
+294.0%
32,880
+169.2%
0.00%
Q1 2020$218,000
-37.9%
12,214
+16.2%
0.00%
Q4 2019$351,000
+50.6%
10,515
+7.2%
0.00%
Q3 2019$233,000
-22.3%
9,805
+17.6%
0.00%
Q2 2019$300,000
-54.1%
8,341
-45.1%
0.00%
Q4 2018$653,000
-24.0%
15,181
-16.5%
0.00%
Q3 2018$859,000
-8.5%
18,189
-3.6%
0.00%
Q2 2018$939,000
+1816.3%
18,871
+1806.2%
0.00%
Q1 2018$49,0009900.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Horton Capital Management, LLC 684,749$11,517,00023.27%
GREAT POINT PARTNERS LLC 750,000$12,615,0002.94%
HealthInvest Partners AB 75,000$1,262,0001.89%
Wildcat Capital Management, LLC 533,139$8,967,0001.16%
Annandale Capital, LLC 86,254$1,451,0000.87%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$49,698,0000.73%
ZEKE CAPITAL ADVISORS, LLC 723,677$12,172,0000.70%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$426,0000.34%
RTW INVESTMENTS, LP 857,464$14,423,0000.22%
SHIKIAR ASSET MANAGEMENT INC 33,350$561,0000.16%
View complete list of UROGEN PHARMA LTD shareholders